| DC Field | Value | Language |
|---|
| dc.contributor.author | Matcovschi, Sergiu | |
| dc.contributor.author | Agachi, Svetlana | |
| dc.contributor.author | Ciuhrii, Veaceslav | |
| dc.contributor.author | Cornea, Natalia | |
| dc.contributor.author | Tofan, Valentin | |
| dc.date.accessioned | 2019-06-11T10:18:53Z | |
| dc.date.available | 2019-06-11T10:18:53Z | |
| dc.date.issued | 2017 | |
| dc.identifier.citation | MATCOVSCHI, Sergiu; AGACHI, Svetlana; CIUHRII, Veaceslav; CORNEA, Natalia; TOFAN, Valentin. Eficacitatea cremei SPONDI-LIZ (newtone laboratories SRL, România) în osteoartroza deformantă / gonartroză (rezultatele evaluării WOMAC ). In: Sănătate Publică, Economie şi Management în Medicină. 2017, nr. 3(73), pp. 145-149. ISSN 1729-8687. | en_US |
| dc.identifier.issn | 1729-8687 | |
| dc.identifier.uri | http://repository.usmf.md/handle/20.500.12710/1450 | |
| dc.identifier.uri | http://revistaspemm.md/wp-content/uploads/2019/04/cm3_73_2017cg-2.pdf | |
| dc.description | IP USMF Nicolae Testemițanu, NEWTONE LABORATORIES | en_US |
| dc.description.abstract | High clinical efficacy, safety, tolerance and lack of adverse
effects during treatment with SPONDI-LIZ cream has been
demonstrated in 140 patients with deforming osteoarthrosis
based on WOMAC scale evaluation. Analysis of the “Pain”
WOMAC section revealed an improvement of 1-8 points,
averaging 3.91±1.13 points after 4 weeks of treatment
(representing 10-72.7% from the baseline). „Stiffness”
section has improved with 0-2 points (1,79±0,59 points or
42,26±14,92%). „Physical functioning” has increased with
11-26 points (14,96±1,83 points or 42,35±5,11%). | en_US |
| dc.language.iso | ro | en_US |
| dc.publisher | Asociația Obștească "Economie, Management și Psihologie în Medicină" din Republica Moldova | en_US |
| dc.relation.ispartof | Sănătate Publică, Economie şi Management în Medicină: Al III-lea Congres al medicilor interniști din Republica Moldova cu participare internațională 24–25 octombrie 2017 Chișinău, Republica Moldova | |
| dc.subject.ddc | CZU 616.728.3-007.248:615.276 | |
| dc.subject.mesh | Osteoarthritis, Knee--drug therapy | en_US |
| dc.subject.mesh | Joint Diseases--drug therapy | en_US |
| dc.subject.mesh | Rheumatic Diseases--drug therapy | en_US |
| dc.subject.mesh | Spondi-Liz--therapeutic use | en_US |
| dc.subject.mesh | Osteoarthritis--classification | en_US |
| dc.subject.mesh | Ointments--therapeutic use | en_US |
| dc.subject.mesh | Patient Acuity | en_US |
| dc.title | Eficacitatea cremei SPONDI-LIZ (Newtone Laboratories SRL, România) în osteoartroza deformantă / gonartroză (rezultatele evaluării WOMAC ) | en_US |
| dc.title.alternative | SPONDI-LIZ cream (Newtone Laboratories SRL, Romania) efficacy in deforming osteoarthrosis (results of WOMAC assessment) | en_US |
| dc.type | Other | en_US |
| Appears in Collections: | Sănătate Publică, Economie şi Management în Medicină Nr. 3 (73) / 2017
|
